Skip to main content
. 2020 Feb;26(2):10.18553/jmcp.2020.26.2.197. doi: 10.18553/jmcp.2020.26.2.197

TABLE 2.

Multivariable Adjusted ORs for Continuing Treatment Among Women Receiving BP

Predictor OR (95% CI)
Age, years
  50-59 1
  60-69 0.98 (0.92-1.04)
  70-79 1.06 (1.00-1.13)
  ≥ 80 1.00 (0.93-1.07)
Race/ethnicity
  White 1
  African American/black 0.93 (0.86-1.01)
  Hispanic/Latina 0.89 (0.85-0.94)
  Asian/Pacific Islander 0.90 (0.85-0.94)
  Current smoking 1.04 (0.96-1.14)
  Low education census block 1.04 (0.99-1.10)
  Low income census block 1.05 (0.97-1.13)
  Index year (year of cohort entry) < 2008 1.35 (1.29-1.41)
BMI category (kg/m2)
  Normal/underweight (BMI < 25) 1
  Overweight (BMI 25-< 30) 0.99 (0.95-1.03)
  Obese (BMI ≥ 30) 1.00 (0.94-1.05)
Charlson Comorbidity Index score
  0 1
  1 0.99 (0.94-1.05)
  2 0.97 (0.91-1.03)
  > 2 0.91 (0.84-0.98)
History of medical conditions
  Diabetes 1.08 (1.01-1.16)
  Rheumatoid arthritis 0.89 (0.80-0.99)
Chronic kidney disease
    Grade 3a 1.00 (0.95-1.06)
    Grade 3b 0.91 (0.82-1.00)
Other medication use
  Proton pump inhibitors 0.65 (0.59-0.71)
  Aromatase inhibitors 0.92 (0.69-1.24)
  Glucocorticoids 1.01 (0.89-1.13)
History of fractures before BP initiation
  Hip 0.90 (0.80-1.01)
  Spine 0.98 (0.84-1.15)
  Humerus 0.95 (0.82-1.10)
  Wrist 1.06 (0.94-1.18)
  Other skeletal site 0.95 (0.90-1.01)
History of fractures in previous 12 months
  Hip 0.61 (0.52-0.71)
  Spine 0.87 (0.76-1.00)
  Humerus 0.79 (0.66-0.94)
  Wrist 1.11 (0.96-1.28)
  Other skeletal site 0.90 (0.84-0.97)
BMD T-score
  > −2.0 1
  −2.0 to > −2.5 1.31 (1.25-1.38)
  −2.5 to > −3.0 1.48 (1.39-1.57)
  ≤ −3.0 1.57 (1.47-1.68)
Time on follow-up
  < 6 months 1
  6 months to 1 year 1.16 (1.09-1.24)
  Year 2 1.24 (1.18-1.31)
  Year 3 1.29 (1.21-1.36)
  Year 4 1.27 (1.19-1.36)
  Year 5 1.26 (1.17-1.36)

BMD = bone mineral density; BMI = body ma ss index; BP = bisphosphonate; CI = confidence inter val; OR = odds ratio.